Lista de obras - Hasan Jafri - Dominio Público Uruguay

A pilot clinical trial of a recombinant ricin vaccine in normal humans.

artículo científico publicado en 2006

A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients

artículo científico publicado en 2009

A systematic review of risk factors associated with surgical site infections among surgical patients

artículo científico publicado en 2013

Alternatives to antibiotics

artículo científico publicado en 2016

Antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis.

artículo científico publicado en 2005

Antibody-based therapy to combat Staphylococcus aureus infections.

artículo científico publicado en 2017

Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia

artículo científico publicado en 2014

Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency

artículo científico publicado en 2005

Diagnostic virology practices for respiratory syncytial virus and influenza virus among children in the hospital setting: a national survey.

artículo científico publicado en 2007

Distribution of Respiratory Syncytial Virus Subtypes A and B Among Infants Presenting to the Emergency Department With Lower Respiratory Tract Infection or Apnea ⬇️

artículo científico publicado el 1 de abril de 2013

Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial.

artículo científico publicado en 2006

Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial

artículo científico publicado en 2009

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

artículo científico publicado en 2015

Healthcare utilization and costs associated with S. aureus and P. aeruginosa pneumonia in the intensive care unit: a retrospective observational cohort study in a US claims database.

artículo científico publicado en 2015

Herpes simplex virus encephalitis during suppressive therapy with acyclovir in a premature infant.

artículo científico publicado en 2005

Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection

artículo científico publicado en 2004

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases

artículo científico publicado en 2004

Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease

artículo científico publicado en 2008

Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients

artículo científico publicado en 2007

MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus

scientific journal article

Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections

artículo científico publicado en 2005

Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model

artículo científico publicado en 2007

Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.

artículo científico publicado en 2001

Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age.

artículo científico publicado en 2008

Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children

artículo científico publicado en 2010

Randomized, Double-Blind Study of the Pharmacokinetics and Safety of Palivizumab Liquid Formulation Compared with Lyophilized Formulation.

artículo científico publicado en 2014

Randomized, Double-Blind Study of the Safety of the Liquid Versus Lyophilized Formulation of Palivizumab in Premature Infants and Children with Chronic Lung Disease of Prematurity.

artículo científico publicado en 2014

Respiratory Syncytial Virus Genotypes, Host Immune Profiles and Disease Severity in Young Children Hospitalized with Bronchiolitis

artículo científico publicado en 2017

Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice

artículo científico publicado en 2004

Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model

artículo científico publicado en 2008

Respiratory syncytial virus persistence: evidence in the mouse model.

artículo científico publicado en 2008

Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model

artículo científico publicado en 2005

Safety experience with caspofungin in pediatric patients.

artículo científico publicado en 2009

Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults

artículo científico publicado en 2017

Serious early childhood wheezing after respiratory syncytial virus lower respiratory tract illness in preterm infants.

artículo científico publicado en 2010

Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.

artículo científico publicado en 2008

Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893

artículo científico publicado en 2016

Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin

artículo científico publicado en 2007

The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.

artículo científico publicado en 2015

The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia

artículo científico publicado en 2016

Lista de obras de Hasan Jafri

A pilot clinical trial of a recombinant ricin vaccine in normal humans.

A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients

A systematic review of risk factors associated with surgical site infections among surgical patients

Alternatives to antibiotics

Antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis.

Antibody-based therapy to combat Staphylococcus aureus infections.

Characterization of alpha-toxin hla gene variants, alpha-toxin expression levels, and levels of antibody to alpha-toxin in hemodialysis and postsurgical patients with Staphylococcus aureus bacteremia

Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency

Diagnostic virology practices for respiratory syncytial virus and influenza virus among children in the hospital setting: a national survey.

Distribution of Respiratory Syncytial Virus Subtypes A and B Among Infants Presenting to the Emergency Department With Lower Respiratory Tract Infection or Apnea ⬇️

Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial.

Effect of dexamethasone on respiratory syncytial virus-induced lung inflammation in children: results of a randomized, placebo controlled clinical trial

Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial

Healthcare utilization and costs associated with S. aureus and P. aeruginosa pneumonia in the intensive care unit: a retrospective observational cohort study in a US claims database.

Herpes simplex virus encephalitis during suppressive therapy with acyclovir in a premature infant.

Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases

Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease

Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients

MAVS and MyD88 are essential for innate immunity but not cytotoxic T lymphocyte response against respiratory syncytial virus

Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections

Motavizumab, a neutralizing anti-Respiratory Syncytial Virus (Rsv) monoclonal antibody significantly modifies the local and systemic cytokine responses induced by Rsv in the mouse model

Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.

Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age.

Pharmacokinetics, safety, and tolerability of voriconazole in immunocompromised children

Randomized, Double-Blind Study of the Pharmacokinetics and Safety of Palivizumab Liquid Formulation Compared with Lyophilized Formulation.

Randomized, Double-Blind Study of the Safety of the Liquid Versus Lyophilized Formulation of Palivizumab in Premature Infants and Children with Chronic Lung Disease of Prematurity.

Respiratory Syncytial Virus Genotypes, Host Immune Profiles and Disease Severity in Young Children Hospitalized with Bronchiolitis

Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice

Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model

Respiratory syncytial virus persistence: evidence in the mouse model.

Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model

Safety experience with caspofungin in pediatric patients.

Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults

Serious early childhood wheezing after respiratory syncytial virus lower respiratory tract illness in preterm infants.

Single-dose pharmacokinetics of daptomycin in children with suspected or proved gram-positive infections.

Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893

Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin

The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.

The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia